mike doustdar - Search News

News

Novo Nordisk appoints Mike Doustdar

Yahoo Finance · 3d

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date.

Fast Company on MSN · 3d

NVO stock: Why did Novo Nordisk shares drop 20% today—and who is Maziar Mike Doustdar?

The GLP-1 weight-loss drug giant just cut its investor guidance for 2025. Could the boom be over? Health-related stocks are not having a good day. First, America’s largest health insurance provider, UnitedHealth Group (NYSE: UNH),

Reuters on MSN · 3d

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

3don MSN

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

3don MSN

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

10h

Novo Nordisk Shares Dip Further as Wegovy Gains Nearly Erased

(Reuters) -Shares in Wegovy maker Novo Nordisk fell around 4% on Friday to their lowest since August 2021, after U.S.

Pharma Industry Shaken: New Leadership and Tariff Challenges

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results